Search

  • HOME
  • Search
Letter to the Editor
Letter regarding “Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation”
Yun-Fan Liaw
Clin Mol Hepatol. 2024;30(2):269-271.   Published online January 31, 2024
View: 1236   Download: 24  Crossref: 1
Editorial
Enhancing off-nucleos(t)ide analogue outcome predictions in chronic hepatitis B with time-varying hepatitis B core-related antigen
Chen-Te Huang, Tai-Chung Tseng
Clin Mol Hepatol. 2024;30(2):154-156.   Published online February 22, 2024
View: 1206   Download: 35  Crossref: 1
Letter to the Editor
Letter regarding “Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma”
Chi Hsiao, Yung-Po Liaw
Clin Mol Hepatol. 2024;30(1):109-110.   Published online October 11, 2023
View: 1184   Download: 32
Review
1791
Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
Takako Inoue, Takehisa Watanabe, Yasuhito Tanaka
Clin Mol Hepatol. 2023;29(4):851-868.   Published online March 9, 2023
View: 7031   Download: 353  Web of Science: 8  Crossref: 10
Editorial
The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B
Xianhua Mao, Lung Yi Mak, Wai-Kay Seto
Clin Mol Hepatol. 2023;29(3):690-692.   Published online May 30, 2023
View: 1934   Download: 85  Web of Science: 1  Crossref: 1
Original Article
Tenofovir alafenamide treatment may not worsen the lipid profile of chronic hepatitis B patients: A propensity score-matched analysis
Joonho Jeong, Jung Woo Shin, Seok Won Jung, Eun Ji Park, Neung Hwa Park
Clin Mol Hepatol. 2022;28(2):254-264.   Published online December 28, 2021
View: 5135   Download: 278  Web of Science: 19  Crossref: 21
Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience
Hong Joo Kim, Yong Kyun Cho, Woo Kyu Jeon, Byung Ik Kim
Clin Mol Hepatol. 2017;23(4):323-330.   Published online September 5, 2017
View: 7383   Download: 179  Web of Science: 6  Crossref: 9
Review
1324
New perspectives of biomarkers for the management of chronic hepatitis B
Chih-Lin Lin, Jia-Horng Kao
Clin Mol Hepatol. 2016;22(4):423-431.   Published online December 25, 2016
View: 12965   Download: 545  Web of Science: 48  Crossref: 47
Original Article
Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong
Clin Mol Hepatol. 2014;20(4):355-360.   Published online December 24, 2014
View: 7884   Download: 76  Web of Science: 6  Crossref: 7
Review
Risk stratification of HBV infection in Asia-Pacific region
Jia-Horng Kao
Clin Mol Hepatol. 2014;20(3):223-227.   Published online September 25, 2014
View: 8886   Download: 85  Web of Science: 19  Crossref: 17
Original Article
Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
Sang Hoon Ahn, Ji-Yong Chun, Soo-Kyung Shin, Jun Yong Park, Wangdon Yoo, Sun Pyo Hong, Soo-Ok Kim, Kwang-Hyub Han
Clin Mol Hepatol. 2013;19(4):399-408.   Published online December 28, 2013
View: 6784   Download: 49  Crossref: 2
Clinical significance of occult hepatitis B virus infection in chronic hepatitis C patients
Jae Young Jang, Soung Won Jeong, Sung Ran Cheon, Sae Hwan Lee, Sang Gyune Kim, Young Koog Cheon, Young Seok Kim, Young Deok Cho, Hong Soo Kim, So Young Jin, Yun Soo Kim, Boo Sung Kim
Clin Mol Hepatol. 2011;17(3):206-212.   Published online September 30, 2011
View: 8414   Download: 65  Crossref: 12
3
The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with Lamivudine-resistant chronic hepatitis B infection
Jae Hyeon Moon , Mong Cho , Ki Tae Yoon , Jung Ho Bae , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song
Clin Mol Hepatol. 2008;14(4):503-512.   Published online December 31, 2008
View: 4210   Download: 16  Crossref: 2
The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis
Min Ju Kim , Oh Sang Kwon , Nak So Chung , Seo Young Lee , Hyuk Sang Jung , Dong Kyun Park , Yang Suh Ku , Yu Kyung Kim , Yun Soo Kim , Ju Hyun Kim
Clin Mol Hepatol. 2008;14(1):67-76.   Published online March 20, 2008
View: 5953   Download: 55  Crossref: 9
Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment
Jae Kwon Jung, M.D., Chang Hyeong Lee, M.D., Eun Young Kim, M.D., Jin Tae Jung, M.D., Joon Hyuck Choi, M.D., Ji Min Han, M.D., Myoung In Jin, M.D., Ju Yeon Cho, M.D., Byung Seok Kim, M.D., Im Hee Shin, Ph.D.
Clin Mol Hepatol. 2007;13(4):513-520.   Published online December 20, 2007
View: 3667   Download: 28
7
The Korean Journal of Serum Hepatitis B Virus DHA Level and Hepatocellulor Carcinoma
Seong Gyu Hwang
Clin Mol Hepatol. 2006;12(4):583-586.   Published online January 1, 1970
View: 2392   Download: 15
2
HBV Mutations During Antiviral Therapy in Patients with Chronic Hepatits B
Seong Gyu Hwang
Clin Mol Hepatol. 2005;11(4):311-319.   Published online January 1, 1970
View: 2358   Download: 14
3
Clinical Outcomes after Discontinuation of Lamivudine in Chronic Hepatitis B Patients with Lamivudine Resistant HBV Mutant
Jeong Ki Kim, M.D. Seong Gyu Hwang, M.D. Hyeuk Park, M.D. Hong Youp Choi, M.D. Hyo Jin Cho, B.S. Kwang Hyun Ko, M.D. Sung Pyo Hong, M.D. Pil Won Park, M.D. Nam Keun Kim, Ph.D. and Kyu Sung Rim, M.D.
Clin Mol Hepatol. 2005;11(3):227-242.   Published online January 1, 1970
View: 2969   Download: 14
HBV-specific CD8+ T cells for Sustained HBeAg Seroconversion after Lamivudine Therapy
Chun Kyon Lee, M.D., Kwang-Hyub Han, M.D. Jeong Hun Suh, M.D., Young Suk Cho, M.D., Sun Young Won, M.D., Chae Yoon Chon, M.D. Young Myoung Moon, M.D. and In Suh Park, M.D.
Clin Mol Hepatol. 2005;11(1):34-42.   Published online January 1, 2000
View: 2168   Download: 13
2
Treatment of Chronic Hepatitis B ; Monitoring Patients with Chronic HBV Infection During Antiviral Therapy
Yun Soo Kim
Clin Mol Hepatol. 2005;11(1):9-12.   Published online January 1, 2000
View: 2406   Download: 17
3
Reappraisal of HBV Genotypes and Clinical Significance in Koreans Using MALDI-TOF Mass Spectrometry
Jung Min Lee , Sang Hoon Ahn , Hye Young Chang , Ji Eun Shin , Do Young Kim , Myoung Ki Sim , Sun Pyo Hong , Hyun Jae Chung , Soo Ok Kim , Kwang Hyub Han , Chae Yoon Cho
Clin Mol Hepatol. 2004;10(4):260-270.
View: 2152   Download: 33
Serum ALT and HBV DNA Levels in Patients with HBeAg-Negative Chronic Hepatitis B
Kyung Hwan Kim, M.D., Il Hwan Na, M.D., Jae Moon Cha, M.D., Yong Ki Cho, M.D., Se Young Park, M.D., Hyoung Pil Kim, M.D., Chul Soo Song, M.D., Jeong Heo, M.D. and Mong Cho, M.D.
Clin Mol Hepatol. 2003;9(4):284-292.   Published online January 1, 2000
View: 3024   Download: 29
Clinical and Virologic Characteristics of Lamivudine Resistance in HBV-associated Chronic Liver Disease
Sun Suk Kim, M.D., Moon Gi Chung, M.D., Ki Tak Ju, M.D., Dong Kyun Park, M.D. Oh Sang Kwon, M.D.,Yang Suh Koo, M.D., Yu Kyung Kim, M.D., Duck Ju Choi, M.D. Yu Jin Hwang, Ph.D.* and Ju Hyun Kim, M.D.
Clin Mol Hepatol. 2002;8(4):405-417.   Published online January 1, 1970
View: 2246   Download: 15
Chemokine Receptor Expression of Hepatitis B Virus-Specific CD8+ Lymphocyte in Chronic B Viral Infection
Chun Kyon Lee, M.D. Jeong Hun Suh, M.D. Young Suk Cho, M.D. Kwang-Hyub Han, M.D. Jae Bock Chung, M.D. Chae Yoon Chon, M.D. and Young Myoung Moon, M.D.
Clin Mol Hepatol. 2002;8(4):363-370.   Published online January 1, 2000
View: 2334   Download: 23
The Clinical Significance of Quantitation of HBV DNA in Serum : Comparison of the Branched-DNA Assay with the Second-Generation Digene Hybrid Capture Assay and Long-term Observation
Eun Jung Jun, M.D., Joon-Yeol Han, M.D., Hwang Choi, M.D., U Im Chang, M.D., Tae Kyu Lee, M.D., Young Hwan Kim, M.D., Jin Il Kim, M.D., Soo Heon Park, M.D., Jae Kwang Kim, M.D., Kyu Won Chung, M.D. and Hee Sik Sun, M.D.
Clin Mol Hepatol. 2002;8(2):157-166.   Published online January 1, 2000
View: 2248   Download: 18
Direct Analysis of HBV - Specific CD8+ Lymphocyte By Tetrameric HLA-A2/core 18-27 Complex in Chronic Hepatitis B
Chun Kyon Lee, M.D., Jeong Hun Suh, M.D., Young Suk Cho, M.D., Kwang-Hyub Han, M.D.*, Jae Bock Chung, M.D.*, Chae Yoon Chon, M.D.*, Young Myoung Moon, M.D.*
Clin Mol Hepatol. 2002;8(2):139-148.   Published online January 1, 1970
View: 2247   Download: 17
HBV DNA Levels, Aminotransferase and Histological Activity in Young Male Patients with HBeAg Positive Chronic Hepatitis B
Seung Chul Cho,Soong Hwan Lee,Joon Jae Shinn,Sung Hee Han,Byung Joo Roh,Joo Hyun Sohn,Dong Hoo Lee,Choon Suhk Kee
Clin Mol Hepatol. 2002;8(1):44-51.   Published online January 1, 2000
View: 2643   Download: 28
The Correlation Between The Histologic Activity and Fibrosis and The Distribution of Intrahepatic HBsAg and HBcAg in Patients With Chronic Hepatitis B
Kwang Bum Cho, M.D., Jung Ho Sohn, M.D., Kyung Sik Park, M.D., Du Young Kwon, M.D., Jae Seok Hwang, M.D., Jung Wook Hur, M.D., Sung Hoon Ahn, M.D., Soong Kuk Park, M.D., and Sang Pyo Kim, M.D.*
Clin Mol Hepatol. 2001;7(4):401-412.   Published online January 1, 1970
View: 2241   Download: 17
The Hepatitis B Carrier Rate in Siblings of Patients with HBV - associated Chronic Liver Disease
Hwi Kong, M.D., Ji Hoon Kim, M.D., Nam Young Cho, M.D., Yoon Hong Kim, M.D., Kil Man Jung, M.D., Jong Eun Yeon, M.D., Jae Seon Kim, M.D., Young Tae Bak, M.D., Kyung Hwan Cho, M.D.*, Yong Kyu Park, M.D.† , Kwan Soo Byun, M.D., and Chang Hong Lee, M.D.
Clin Mol Hepatol. 2001;7(4):387-391.   Published online January 1, 2000
View: 2206   Download: 16
1 | 2 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 132
TOTAL : 1849992
Close layer